Cell lines are common model systems in the development of therapeutic proteins and in the research on cellular functions and dysfunctions. In this field, the protein interaction assay is a frequently used tool for assessing the adequacy of a protein for diagnostic and therapeutic purposes. In this study, we investigated the extent to which the interaction characteristics depend on the choice of cell line for HER-family receptors. The interaction characteristics of two therapeutic antibodies (trastuzumab and cetuximab) and one Affibody molecule (ZHER2:342), interacting with the intended receptor were characterized with high precision using an automated real-time interaction method, in different cell lines (HaCaT, A431, HEP-G2, SKOV3, PC3, DU-145). Clear differences in binding affinity and kinetics, up to one order of magnitude, were found for the interaction of the same protein binding to the same receptor on different cells for all three proteins. For HER-family receptors, it is therefore important to refer to the measured affinity for a protein-receptor interaction together with the hosting cell line. The ability to accurately measure affinity and kinetics of a protein-receptor interaction on cell lines of different origins may increase the understanding of underlying receptor biology, and impact the selection of candidates in the development of therapeutic or diagnostic agents.

Department of Pharmacology and Toxicology Faculty of Pharmacy in Hradec Kralove Charles University Prague Heyrovského 1203 50005 Hradec Králové Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc12024160

003      

CZ-PrNML

005      

20121207110305.0

007      

ta

008      

120815s2012 gr f 000 0#eng||

009      

AR

024    7_

$a 10.3892/ijo.2011.1307 $2 doi

035    __

$a (PubMed)22200885

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a gr

100    1_

$a Barta, Pavel $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovského 1203, 50005 Hradec Králové, Czech Republic.

245    10

$a Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line / $c P. Barta, J. Malmberg, L. Melicharova, J. Strandgård, A. Orlova, V. Tolmachev, M. Laznicek, K. Andersson,

520    9_

$a Cell lines are common model systems in the development of therapeutic proteins and in the research on cellular functions and dysfunctions. In this field, the protein interaction assay is a frequently used tool for assessing the adequacy of a protein for diagnostic and therapeutic purposes. In this study, we investigated the extent to which the interaction characteristics depend on the choice of cell line for HER-family receptors. The interaction characteristics of two therapeutic antibodies (trastuzumab and cetuximab) and one Affibody molecule (ZHER2:342), interacting with the intended receptor were characterized with high precision using an automated real-time interaction method, in different cell lines (HaCaT, A431, HEP-G2, SKOV3, PC3, DU-145). Clear differences in binding affinity and kinetics, up to one order of magnitude, were found for the interaction of the same protein binding to the same receptor on different cells for all three proteins. For HER-family receptors, it is therefore important to refer to the measured affinity for a protein-receptor interaction together with the hosting cell line. The ability to accurately measure affinity and kinetics of a protein-receptor interaction on cell lines of different origins may increase the understanding of underlying receptor biology, and impact the selection of candidates in the development of therapeutic or diagnostic agents.

650    _2

$a monoklonální protilátky $x metabolismus $7 D000911

650    _2

$a humanizované monoklonální protilátky $x metabolismus $7 D061067

650    _2

$a afinita protilátek $7 D000915

650    _2

$a buňky Hep G2 $7 D056945

650    _2

$a lidé $7 D006801

650    _2

$a radioizotopy jodu $7 D007457

650    _2

$a kinetika $7 D007700

650    _2

$a vazba proteinů $7 D011485

650    _2

$a interakční proteinové domény a motivy $7 D054730

650    _2

$a mapování interakce mezi proteiny $7 D025941

650    _2

$a radioligandová zkouška $7 D011869

650    _2

$a erbB receptory $x metabolismus $7 D066246

650    _2

$a receptor erbB-2 $x metabolismus $7 D018719

650    _2

$a rekombinantní fúzní proteiny $x metabolismus $7 D011993

655    _2

$a srovnávací studie $7 D003160

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Malmberg, Jennie

700    1_

$a Melicharova, Ludmila

700    1_

$a Strandgård, John

700    1_

$a Orlova, Anna

700    1_

$a Tolmachev, Vladimir

700    1_

$a Laznicek, Milan

700    1_

$a Andersson, Karl $7 gn_A_00006202

773    0_

$w MED00002350 $t International journal of oncology $x 1791-2423 $g Roč. 40, č. 5 (2012), s. 1677-82

856    41

$u https://pubmed.ncbi.nlm.nih.gov/22200885 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y m

990    __

$a 20120815 $b ABA008

991    __

$a 20121207110339 $b ABA008

999    __

$a ok $b bmc $g 946308 $s 781488

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2012 $b 40 $c 5 $d 1677-82 $i 1791-2423 $m International journal of oncology $n Int J Oncol $x MED00002350

LZP    __

$a Pubmed-20120815/12/02